Eric Shahinian - 29 Aug 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ Eric Shahinian
Issuer symbol
KTTA
Transactions as of
29 Aug 2022
Transactions value $
$26,293
Form type
4
Filing time
31 Aug 2022, 16:32:16 UTC
Previous filing
18 Aug 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $5,840 +5,000 +0.31% $1.17 1,617,329 29 Aug 2022 See footnote F1, F2
transaction KTTA Common Stock Purchase $20,452 +17,828 +1.1% $1.15 1,635,157 30 Aug 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares beneficially owned includes 1,000 shares inadvertently omitted from the Reporting Persons' Form 3 filed 08/15/2022.
F2 The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.